UTC officials have just suspended the use of the Johnson and Johnson vaccinations on campus.
Here’s the information released to campus
Out of an abundance of caution and under recommendations by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), UTC is suspending administration of the Johnson & Johnson COVID-19 vaccine at this time due to a pending clinical review of medical cases by the FDA and CDC. The Thursday, April 15, Johnson & Johnson COVID-19 Vaccine Clinic to be held on campus at the Collins Street Annex is now canceled.
Six Johnson & Johnson vaccine recipients in the U.S. who are women between the ages of 18 and 48 developed a rare disorder involving blood clots within about two weeks of vaccination. These six cases are among more than 6.8 million doses which have been given so far. For more on the CDC and FDA position regarding this pause, please click here.
As always, in the event of any side effects that may be related to a vaccination received, you should report them to the Vaccine Adverse Event Reports System (VAERS) by clicking here.
The Moderna second-dose immunization clinic scheduled for Friday, April 16, will go on as scheduled. The University will furnish additional information to the campus community as it becomes available.
Christine Benz Smith, PhD, FNP-BC
Chief Health Affairs Officer
University of Tennessee at Chattanooga